Status: current, Defined. Date: 31-Mar 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1558571000168119 | cobicistat 150 mg + elvitegravir 150 mg + emtricitabine 200 mg + tenofovir alafenamide 10 mg tablet, 30 tablets (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1558581000168116 | tenofovir alafenamide 10 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat 150 mg tablet, 30 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| tenofovir alafenamide 10 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat 150 mg tablet, 30 | Is a | cobicistat 150 mg tablet, 30 | true | Inferred relationship | Some | ||
| tenofovir alafenamide 10 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat 150 mg tablet, 30 | Is a | medicinal product pack | false | Inferred relationship | Some | ||
| tenofovir alafenamide 10 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat 150 mg tablet, 30 | has MPUU | tenofovir alafenamide 10 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat 150 mg tablet | true | Inferred relationship | Some | 1 | |
| tenofovir alafenamide 10 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat 150 mg tablet, 30 | Is a | emtricitabine 200 mg + tenofovir alafenamide 10 mg tablet, 30 | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Genvoya tablet, 30 | Is a | True | tenofovir alafenamide 10 mg + emtricitabine 200 mg + elvitegravir 150 mg + cobicistat 150 mg tablet, 30 | Inferred relationship | Some |
Reference Sets
List of Excluded Medicinal Items reference set
Medicinal product pack reference set
FHIR